Figure 1
From: SWR/J mice are susceptible to alkylator-induced myeloid leukemia

Kaplan–Meier analysis of overall survival in ENU-treated mice. (a) Overall survival was decreased in ENU-treated mice compared with controls (P=0.004; Tukey-adjusted log rank). Administration of HC before ENU extended median and overall survival slightly compared with ENU alone or HC after ENU (P<0.0001). (b) The cumulative probability of lymphoma was higher than that of myeloid leukemia (48.4% vs 23.9%), but occurred with identical latency (134 days after ENU exposure).